https://www.selleckchem.com/pr....oducts/gusacitinib.h
7% [95% confidence interval 84.7-100] versus 88.4% [82.5-94.3], P=.056; 2-year overall survival 92.7% [84.7-100] versus 93.7% [89.2-98.2], P=.176), but this was restricted to patients below the age of 60years (2-year progression-free survival 100% versus 92.2% [84.8-99.6], P=.031; 2-year overall survival 100% versus 95.9% [90.2-100], P=.075). In peripheral T-cell lymphoma, eight of 11 patients had completely resected disease. In contrast to DLBCL, complete resection was not associated with improved outcome compared to the control. Y
Like
Comment
Share
